Evidence map›Paper›PMID 34215475›Full record

ArticleJournal of substance abuse treatment2022

COVID-19 related substance use services policy changes: Policymaker perspectives on policy development & implementation.

Brandy F Henry, Aimee Campbell, Timothy Hunt, Jessica K Johnson, Amar D Mandavia, Michael Chaple, Caroline Arout, Elwin Wu, Harold A Pincus, Edward V Nunes and 3 more

Abstract read
In one paragraph

Article in Journal of substance abuse treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Brandy F HenryColumbia University School of Social Work, 1255 Amsterdam Ave., New York, NY 10027, United States of America; College of Education, Pennsylvania State University, University Park, PA, 16802 United States of America. Electronic address: bhenry@brandeis.edu.
Aimee CampbellClinical Psychiatric Social Work at Columbia University Irving Medical Center, Department of Psychiatry and Research Scientist at New York State Psychiatric Institute in the Division on Substance Use Disorders, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: anc2002@cumc.columbia.edu.
Timothy HuntColumbia University School of Social Work, 1255 Amsterdam Ave., New York, NY 10027, United States of America. Electronic address: th2258@columbia.edu.
Jessica K JohnsonColumbia University School of Social Work, 1255 Amsterdam Ave., New York, NY 10027, United States of America. Electronic address: jlk2227@columbia.edu.
Amar D MandaviaColumbia University Teachers College, 525 West 120th Street, New York, NY 10027, United States of America. Electronic address: adm2183@tc.columbia.edu.
Michael ChapleDivision on Substance Use Disorders New York State Psychiatric Institute, Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: Michael.Chaple@nyspi.columbia.edu.
Caroline AroutClinical Neurobiology, Columbia University Irving Medical Center, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: Caroline.Arout@nyspi.columbia.edu.
Elwin WuColumbia University School of Social Work, 1255 Amsterdam Ave., New York, NY 10027, United States of America. Electronic address: ew157@columbia.edu.
Harold A PincusDepartment of Psychiatry, Irving Institute for Clinical and Translational Research, Columbia University, RAND Corporation, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: Harold.Pincus@nyspi.columbia.edu.
Edward V NunesColumbia University Irving Medical Center, Department of Psychiatry, Division on Substance Use Disorders, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: edward.nunes@nyspi.columbia.edu.
Pat LincourtAddiction Treatment and Recovery Division, Office of Addiction Services and Supports, 1450 Western Ave, Albany, NY 12203, United States of America. Electronic address: Pat.Lincourt@oasas.ny.gov.
Frances R LevinColumbia University Irving Medical Center, Department of Psychiatry, Division on Substance Use Disorders, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, United States of America. Electronic address: Frances.Levin@nyspi.columbia.edu.
Nabila El-BasselColumbia University School of Social Work, 1255 Amsterdam Ave., New York, NY 10027, United States of America. Electronic address: ne5@columbia.edu.

Funding

Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
Improving HIV Service Delivery for People who Inject Drugs in KazakhstanR01DA041063 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI EL-BASSEL, NABILA, GILBERT, LOUISA · 2015 to 2019
$4.7M
NIDA NIH HHS R01 DA041063NIDA NIH HHS T32 DA037801
6 · The paper itself

Abstract

introductionDue to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines.

methodsUsing in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State.

resultsDuring the COVID-19 pandemic, policymakers shifted to more inclusive approaches of knowledge generation and co-production of recommendations. Barriers to adoption and implementation of new regulations included medication/services supply, lack of integration, stigma, and overcriminalization.

conclusionFindings from this study highlight the potential feasibility and benefits of co-produced policies for substance use services and the need for consistent service supply, better integration with health care services, reduced stigma, improved funding structures, best practice guidelines, criminal justice reform, and harm reduction support. These considerations should inform future policy maintenance and modifications to substance use services related to COVID-19.

Indexed as

COVID-19Substance-Related DisordersHumansPandemicsPolicyPolicy MakingSARS-CoV-2COVID-19ImplementationQualitativeSubstance use services policy

Identifiers

PMID34215475
PMCPMC8709868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.